Barak Ben Arye is General Counsel of NovoCure Ltd. Currently has a direct ownership of 118,052 shares of NVCR, which is worth approximately $3.62 Million. The most recent transaction as insider was on Jun 28, 2024, when has been sold 930 shares (Ordinary Shares) at a price of $12.24 per share, resulting in proceeds of $11,383. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 118K
0% 3M change
235.42% 12M change
Total Value Held $3.62 Million

Barak Ben Arye Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 28 2024
BUY
Grant, award, or other acquisition
$11,383 $12.24 p/Share
930 Added 0.78%
118,052 Ordinary Shares
Feb 27 2024
BUY
Grant, award, or other acquisition
$1,333,323 $16.3 p/Share
81,799 Added 41.12%
117,122 Ordinary Shares
Dec 31 2023
BUY
Grant, award, or other acquisition
$1,624 $12.69 p/Share
128 Added 0.36%
35,323 Ordinary Shares
Jun 30 2023
BUY
Grant, award, or other acquisition
$10,160 $35.28 p/Share
288 Added 0.81%
35,195 Ordinary Shares
Feb 28 2023
BUY
Grant, award, or other acquisition
-
17,755 Added 33.72%
34,907 Ordinary Shares
Jan 06 2023
BUY
Grant, award, or other acquisition
$9,345 $62.3 p/Share
150 Added 0.87%
17,152 Ordinary Shares
Jul 05 2022
BUY
Grant, award, or other acquisition
$8,508 $59.08 p/Share
144 Added 0.84%
17,002 Ordinary Shares
BBA

Barak Ben Arye

General Counsel
Malvern, PA

Track Institutional and Insider Activities on NVCR

Follow NovoCure Ltd and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVCR shares.

Notify only if

Insider Trading

Get notified when an Novo Cure LTD insider buys or sells NVCR shares.

Notify only if

News

Receive news related to NovoCure Ltd

Track Activities on NVCR